JP2004210715A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004210715A5 JP2004210715A5 JP2002382121A JP2002382121A JP2004210715A5 JP 2004210715 A5 JP2004210715 A5 JP 2004210715A5 JP 2002382121 A JP2002382121 A JP 2002382121A JP 2002382121 A JP2002382121 A JP 2002382121A JP 2004210715 A5 JP2004210715 A5 JP 2004210715A5
- Authority
- JP
- Japan
- Prior art keywords
- osteoclast formation
- formation inhibitor
- sulfated glycosaminoglycan
- inhibitor according
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002382121A JP4567942B2 (ja) | 2002-12-27 | 2002-12-27 | 破骨細胞形成抑制剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002382121A JP4567942B2 (ja) | 2002-12-27 | 2002-12-27 | 破骨細胞形成抑制剤 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2004210715A JP2004210715A (ja) | 2004-07-29 |
JP2004210715A5 true JP2004210715A5 (it) | 2006-02-09 |
JP4567942B2 JP4567942B2 (ja) | 2010-10-27 |
Family
ID=32817794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002382121A Expired - Fee Related JP4567942B2 (ja) | 2002-12-27 | 2002-12-27 | 破骨細胞形成抑制剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4567942B2 (it) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0401069D0 (sv) | 2004-04-26 | 2004-04-26 | Anamar Medical Ab | Use of Compounds for the Treatment of Diseases and Conditions |
JPWO2006068146A1 (ja) * | 2004-12-20 | 2008-06-12 | 生化学工業株式会社 | 新規コンドロイチン硫酸画分 |
JP5153324B2 (ja) * | 2005-03-14 | 2013-02-27 | 生化学工業株式会社 | 硬組織形成促進剤 |
JP5051999B2 (ja) * | 2005-11-17 | 2012-10-17 | 国立大学法人名古屋大学 | 炎症性骨・軟骨疾患の処置剤 |
JP2007224286A (ja) * | 2006-01-25 | 2007-09-06 | Tottori Univ | 生体組織からの多糖類の取得方法 |
JP5099617B2 (ja) * | 2006-03-16 | 2012-12-19 | 国立大学法人東京農工大学 | 歯周病予防・治療剤 |
JP5063940B2 (ja) * | 2006-06-20 | 2012-10-31 | 生化学工業株式会社 | コンドロイチン硫酸・鉄コロイド製剤及びその製造方法 |
WO2008102568A1 (ja) * | 2007-02-22 | 2008-08-28 | Pg Research Co., Ltd. | 骨軟骨形成促進剤 |
AU2010328726B2 (en) * | 2009-12-09 | 2017-01-19 | Agency For Science, Technology And Research | Glycosaminoglycan mixtures |
DK2707396T3 (en) * | 2011-05-12 | 2019-01-28 | Gnosis Spa | Biotechnological sulfated chondroitin sulfate at position 4 or 6 on the same polysaccharide chain and process for its preparation |
CN105924544B (zh) * | 2016-05-16 | 2018-03-09 | 山东大学 | 一种高硫酸化硫酸软骨素及其制备方法与应用 |
-
2002
- 2002-12-27 JP JP2002382121A patent/JP4567942B2/ja not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP055722A (es) | Mezclas de polisacaridos derivados de heparina, su preparacion y las composiciones farmaceuticas que las contienen | |
JP2004210715A5 (it) | ||
Draget et al. | Ionic and acid gel formation of epimerised alginates; the effect of AlgE4 | |
Alban et al. | Partial synthetic glucan sulfates as potential new antithrombotics: a review | |
AU2001269478B2 (en) | Hyaluronic acid oligosaccharide fractions and drugs containing the same | |
AU2003275958A1 (en) | Muteins of tear lipocalin | |
DK0928206T3 (da) | Hydrokolloid sårgel | |
BR0113663A (pt) | Composições de pelìcula de pectina | |
DE69518333T2 (de) | Polysaccharide mit hohem anteil an iduronsäure | |
Barbucci et al. | Immobilisation of sulphated hyaluronan for improved biocompatibility | |
JP2011513034A5 (it) | ||
CA2637753A1 (en) | Fabric care compositions comprising cationic starch | |
MX2009001203A (es) | Muteinas de lipocalina lacrimosa y metodos para obtener las mismas. | |
Arlov et al. | The impact of chain length and flexibility in the interaction between sulfated alginates and HGF and FGF-2 | |
Przybylski et al. | HABA-based ionic liquid matrices for UV-MALDI-MS analysis of heparin and heparan sulfate oligosaccharides | |
Linhardt et al. | Low molecular weight dermatan sulfate as an antithrombotic agent structure-activity relationship studies | |
PL375693A1 (en) | Aldonic acid esters, methods for producing the same, and methods for producing pharmaceutical active ingredients coupled to polysaccharides or polysaccharide derivatives on free amino groups | |
Jacobsson et al. | Biosynthesis of heparin. Effects of n-butyrate on cultured mast cells. | |
TW200704403A (en) | Dilution resistant viscoelastic compositions | |
KR102007554B1 (ko) | N-탈황화된 글리코스아미노글리칸 유도체 및 약물로서의 용도 | |
TW200745154A (en) | Oligosaccharides derived from fucoidan | |
PL375088A1 (en) | Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation | |
JP2002145779A5 (it) | ||
ITMI20132116A1 (it) | Associazione di glicosamminoglicani e ciclodestrine | |
WO2005010051A3 (fr) | Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant |